Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Your second dynamic answer will appear here after calculation
Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026
view test results Secured Payment All products are for laboratory research purposes only
Supplement Success Rates High-dose oral supplements (1000-2000 micrograms daily) prove effective for many patients with mild to moderate deficiency
US$ 24.85
US$ 21.86
US$ 26.73
US$ 24.68
,aspect=ignore)
US$ 28.75
US$ 22.81
US$ 20.90
US$ 22.66
